The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles

References

• Venkatesh HS, Tam LT, Woo PJ, et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature. 2017;549(7673):533–537.
   PubMed Web of Science ®Google Scholar
• Hochberg FH, Atai NA, Gonda D, et al. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Expert Rev Mol Diagn. 2014;14(4):439–452.
   PubMed Web of Science ®Google Scholar
• Jaimes C, Poussaint TY. Primary neoplasms of the pediatric brain. Radiol Clin North Am. 2019;57(6):1163–1175.
   PubMed Web of Science ®Google Scholar
• Lulla RR, Saratsis AM, Hashizume R. Mutations in chromatin machinery and pediatric high-grade glioma. Sci Adv. 2016;2(3):e1501354
   PubMed Web of Science ®Google Scholar
• Mackay A, Burford A, Molinari V, et al. Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial. Cancer Cell. 2018;33(5):829–842. e825,
   PubMed Web of Science ®Google Scholar
• Fan K, Jia X, Zhou M, et al. Ferritin nanocarrier traverses the blood brain barrier and kills glioma. ACS Nano. 2018;12(5):4105–4115.
   PubMed Web of Science ®Google Scholar
• Tang W, Fan W, Lau J, et al. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev. 2019;48(11):2967–3014.
   PubMed Web of Science ®Google Scholar
• Watkins S, Robel S, Kimbrough IF, et al. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun. 2014;5:4196
   PubMed Web of Science ®Google Scholar
• Li X-Y, Zhao Y, Sun M-G, et al. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Biomaterials. 2014;35(21):5591–5604.
   PubMed Web of Science ®Google Scholar
• Feng X, Yao J, Gao X, et al. Multi-targeting peptide-functionalized nanoparticles recognized vasculogenic mimicry, tumor neovasculature, and glioma cells for enhanced anti-glioma therapy. ACS Appl Mater Interfaces. 2015;7(50):27885–27899.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mei L, Yu Q, et al. Multifunctional tandem peptide modified paclitaxel-loaded liposomes for the treatment of vasculogenic mimicry and cancer stem cells in malignant glioma. ACS Appl Mater Interfaces. 2015;7(30):16792–16801.
   PubMed Web of Science ®Google Scholar
• Nance E, Zhang C, Shih T-Y, et al. Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano. 2014;8(10):10655–10664.
   PubMed Web of Science ®Google Scholar
• Sofias AM, Dunne M, Storm G, et al. The battle of “nano” paclitaxel. Adv Drug Deliv Rev. 2017;122:20–30.
   PubMed Web of Science ®Google Scholar
• Efferth T. From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol. 2017;46:65–83.
   PubMed Web of Science ®Google Scholar
• Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, et al. Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism. Blood. 2016;128(20):2423–2434.
   PubMed Web of Science ®Google Scholar
• Nomura N, Verdon G, Kang HJ, et al. Structure and mechanism of the mammalian fructose transporter GLUT5. Nature. 2015;526(7573):397–401.
   PubMed Web of Science ®Google Scholar
• Ju R-J, Mu L-M, Li X-T, et al. Development of functional docetaxel nanomicelles for treatment of brain glioma. Artif Cells Nanomed Biotechnol. 2018;46(sup1):1180–1190.
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng L, Xie H-J, et al. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2018;46(sup2):1154–1169.
   PubMed Web of Science ®Google Scholar
• Li X-T, Tang W, Xie H-J, et al. The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma. J Liposome Res. 2019;29(1):21–34.
   PubMed Web of Science ®Google Scholar
• Liu J-J, Tang W, Fu M, et al. Development of R8 modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):1947–1960.
   PubMed Web of Science ®Google Scholar
• Giese A, Bjerkvig R, Berens ME, et al. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21(8):1624–1636.
   PubMed Web of Science ®Google Scholar
• van Tellingen O, Yetkin-Arik B, de Gooijer MC, et al. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1–12.
   PubMed Web of Science ®Google Scholar
• Liebner S, Dijkhuizen RM, Reiss Y, et al. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311–336.
   PubMed Web of Science ®Google Scholar
• Zhou W, Chen C, Shi Y, et al. Targeting glioma stem cell-derived pericytes disrupts the blood-tumor barrier and improves chemotherapeutic efficacy. Cell Stem Cell. 2017;21(5):591–603. e594.
   PubMed Web of Science ®Google Scholar
• Shen X, Burguillos MA, Osman AM, et al. Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype. Nat Immunol. 2016;17(11):1282–1290.
   PubMed Web of Science ®Google Scholar
• Rogers C, Erkes DA, Nardone A, et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10(1):1689
   PubMed Web of Science ®Google Scholar
• Giampazolias E, Zunino B, Dhayade S, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19(9):1116–1129.
   PubMed Web of Science ®Google Scholar
• Nagarajan A, Dogra SK, Sun L, et al. Paraoxonase 2 facilitates pancreatic cancer growth and metastasis by stimulating GLUT1-mediated glucose transport. Mol Cell. 2017;67(4):685–701. e686.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang J, Fu Z, et al. Sevoflurane suppresses migration and invasion of glioma cells by regulating miR-146b-5p and MMP16. Artif Cells Nanomed Biotechnol. 2019;47(1):3306–3314.
   PubMed Web of Science ®Google Scholar
• Talasila KM, Soentgerath A, Euskirchen P, et al. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathol. 2013;125(5):683–698.
   PubMed Web of Science ®Google Scholar
• Depner C, Zum Buttel H, Böğürcü N, et al. EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance. Nat Commun. 2016;7:12329.
   PubMed Web of Science ®Google Scholar
• Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533–548.
   PubMed Web of Science ®Google Scholar
• LaGory EL, Giaccia AJ. The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol. 2016;18(4):356–365.
   PubMed Web of Science ®Google Scholar
• Kim Y, Nam HJ, Lee J, et al. Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis. Nat Commun. 2016;7:10347.
   PubMed Web of Science ®Google Scholar
• Du R, Lu KV, Petritsch C, et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008;13(3):206–220.
   PubMed Web of Science ®Google Scholar
• Kim Y-J, Lee H-J, Kim T-M, et al. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. Int J Cancer. 2013;132(1):29–41.
   PubMed Web of Science ®Google Scholar
• Qin C, He B, Dai W, et al. The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. Biomaterials. 2014;35(22):5908–5920.
   PubMed Web of Science ®Google Scholar
• Goncalves-Ribeiro S, Sanz-Pamplona R, Vidal A, et al. Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling. Ann Oncol. 2017;28:2160–2168.
   PubMed Web of Science ®Google Scholar
• Andeol Y, Bonneau J, Gagné LM, et al. The phosphoinositide 3-kinase pathway and glycogen synthase kinase-3 positively regulate the activity of metal-responsive transcription factor-1 in response to zinc ions. Biochem Cell Biol. 2018;96(6):726–733.
   Web of Science ®Google Scholar
• Hanker AB, Kaklamani V, Arteaga CL. Challenges for the clinical development of PI3K inhibitors: strategies to improve their impact in solid tumors. Cancer Discov. 2019;9(4):482–491.
   PubMed Web of Science ®Google Scholar
• Jain P, Surrey LF, Straka J, et al. Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation. Acta Neuropathol. 2018;136(1):167–169.
   PubMed Web of Science ®Google Scholar